Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on expanding vaccine manufacturing capacity.Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on expanding vaccine manufacturing capacity.United States Politics and Government, American Rescue Plan (2021), Coronavirus (2019-nCoV), Vaccination and Immunization, Drugs (Pharmaceuticals), Biden, Joseph R Jr, BioNTech SE, Moderna Inc, Pfizer Inc, Novavax Inc, Johnson & Johnson, CovaxRead More
